The Pharmagellan Guide to Biotech Forecasting and Valuation
Authors
Parameters
Categories
More about the book
If you're a biotech executive, investor, deal maker, entrepreneur, or adviser-or aspire to be one-then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs. The Pharmagellan Guide is a comprehensive, thoroughly referenced handbook for early-stage biopharma assets and companies.
Book purchase
The Pharmagellan Guide to Biotech Forecasting and Valuation, Andrew Matthews, Frank S. David, Seth Robey
- Language
- Released
- 2017
We’ll notify you via email once we track it down.
Payment methods
- Title
- The Pharmagellan Guide to Biotech Forecasting and Valuation
- Language
- English
- Authors
- Andrew Matthews, Frank S. David, Seth Robey
- Publisher
- Pharmagellan
- Released
- 2017
- Format
- Paperback
- ISBN10
- 099840750X
- ISBN13
- 9780998407500
- Category
- Business and Economics
- Description
- If you're a biotech executive, investor, deal maker, entrepreneur, or adviser-or aspire to be one-then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs. The Pharmagellan Guide is a comprehensive, thoroughly referenced handbook for early-stage biopharma assets and companies.